[Surveillance and side-effects of transfusions]

Area of Science:

• Hematology
• Transfusion Medicine

Background:

• Allogenic blood transfusions are essential for managing anemia caused by hematologic diseases, chemotherapy, hemorrhage, or surgery.
• Transfusions prevent anemia's debilitating side effects like hypoxia, tachycardia, and fatigue.

Purpose of the Study:

• To highlight the potential acute and chronic complications associated with allogenic blood transfusions.
• To emphasize the importance of recognizing, preventing, and treating transfusion-related hazards.

Main Methods:

• Review of potential complications, focusing on chronic issues like iron overload (hemochromatosis) and alloimmunization.
• Discussion of management strategies including iron chelation therapy (deferoxamine), ABO-compatible blood selection, filtration, and irradiation of blood products.
• Overview of ongoing research into transfusion substitutes (hemoglobin solutions) and enhancers of hemoglobin synthesis (erythropoietin).

Main Results:

• Frequent transfusions can lead to acute issues (hemolysis, shock) and chronic problems (iron overload, alloimmunization, metabolic disturbances).
• Specific interventions are recommended for managing hemochromatosis and alloimmunization.
• Erythropoietin (EPO) is effective in stimulating hemoglobin synthesis in specific patient populations.

Conclusions:

• Transfusion complications can be severe and potentially fatal, necessitating vigilant management.
• Proactive recognition and treatment of transfusion hazards are critical for patient outcomes.
• Advancements in transfusion alternatives and supportive therapies offer future promise.